Variability of epidermal growth factor receptor (EGFR) mutations in serum during erlotinib therapy and its clinical implications: exploratory analysis of a phase II study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC) harboring
Variability of epidermal growth factor receptor (EGFR) mutations in serum during erlotinib therapy and its clinical implications: exploratory analysis of a phase II study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC) harboring
复制标题
厄洛替尼治疗期间血清中表皮生长因子受体（EGFR）突变的变异性及其临床意义：厄洛替尼治疗晚期非小细胞肺癌（NSCLC）患者的 II 期研究的探索性分析
DOI：
--
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
Tomohide Tamura
中科院分区：
文献类型：
--
作者：
Makoto Maemondo;Makoto Nishio;Noboru Yamamoto;Kenichi Chikamori;Nobuyuki Katakami;Toyoaki Hida;Takashi Seto;Hiroshige Yoshioka;Toshiyuki Kozuki;Norihisa Ohishi;Tomohide Tamura
